subject: PUBCHEM.COMPOUND:149276766

object_name: Cancer (with or without metastasis)


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

tested_intervention: unsure


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6

object_name: metastatic colorectal cancer


subject: CHEBI:149504

object_name: HIV infection


subject: CHEBI:6541

subject_name: Losartan


subject: UNII:I8309403R0

subject_name: Peginterferon beta-1a

object_name: multiple sclerosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:41879

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:43805

object_name: Hodgkin Disease


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: diffuse large B-cell lymphoma


subject: CHEBI:61080

subject_name: Romidepsin


subject: UMLS:C0963679


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: facial nerve disorder

tested_intervention: yes


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: common wart


subject: PR:000002325

subject_name: dynein light chain 1, cytoplasmic

object_name: liver carcinoma


subject: PR:000023552

subject_name: serine recombinase PinE


subject: UNII:4U62D8JYIQ

object_name: inherited lipid metabolism disorder


subject: UNII:4U62D8JYIQ

object_name: Dyslipidemia


subject: CHEMBL.COMPOUND:CHEMBL5315022

subject_name: NELISTOTUG

object_name: neoplasm


subject: UMLS:C5446935

subject_name: Nelistotug


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C4727707


subject: UMLS:C5555024

subject_name: PD-1-positive B-cell Peptide Antigen/MVF IMU-201/Montanide Vaccine

object_name: colorectal cancer


subject: UMLS:C5555024

object_name: colorectal carcinoma


subject: UMLS:C5555024

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Surgical procedure finding


subject: UMLS:C5417967

subject_name: AR Inhibitor EPI-7386

object_name: Castration-Sensitive Prostate Carcinoma


subject: UMLS:C5417967

object_name: prostate adenocarcinoma


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEMBL.COMPOUND:CHEMBL5314984

subject_name: GENTULIZUMAB

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL5314984

object_name: Myelodysplasia


subject: UMLS:C5853526

subject_name: Gentulizumab


subject: UMLS:C5853526


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: prostate neoplasm


subject: CHEBI:63584


subject: MESH:C532412


subject: MESH:C532412


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: cancer


subject: UMLS:C4727210

object_name: nervous system cancer


subject: CHEBI:149504

object_name: diabetic kidney disease


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Intracranial hemorrhage


subject: CHEBI:135967

subject_name: Casopitant

object_name: Vomiting, CTCAE


subject: CHEBI:135967

object_name: Vomiting


subject: UMLS:C1831798


subject: UMLS:C1831798


subject: UNII:WZ9TJ0L9Y8

subject_name: Tinengotinib

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:160283094

subject_name: ZONGERTINIB

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:160283094

object_name: Neoplasm Metastasis


subject: UNII:DRH7R67UVL


subject: UNII:DRH7R67UVL


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Guillain-Barre syndrome, familial


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C4706041

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: malignant germ cell tumor


subject: PUBCHEM.COMPOUND:70789204

object_name: malignant testicular germ cell tumor


subject: PUBCHEM.COMPOUND:70789204

object_name: neoplasm of testis


subject: PUBCHEM.COMPOUND:70789204

object_name: testicular cancer


subject: UMLS:C4733601

object_name: ovarian neoplasm


subject: CHEBI:567361

subject_name: Cladribine

object_name: Myelodysplasia


subject: CHEBI:567361

object_name: graft versus host disease


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UMLS:C0733521

subject_name: Ara-C


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: King's Evil


subject: CHEBI:63611

object_name: latent tuberculosis infection


subject: HMDB:HMDB0015332

subject_name: Rifapentine


subject: CHEBI:134722

subject_name: Favipiravir

object_name: infectious disease


subject: CHEBI:85662

subject_name: Lixisenatide

object_name: maturity-onset diabetes of the young type 1


subject: UMLS:C0305062

subject_name: Tetanus Toxoid

object_name: hepatitis B


subject: UMLS:C0031237

subject_name: pertussis vaccine

object_name: diphtheria


subject: UMLS:C0031237

object_name: tetanus


subject: UMLS:C0031237


subject: UMLS:C0062527

subject_name: Engerix-B


subject: UMLS:C0062527


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:57505028

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:57505028

object_name: breast cancer


subject: CHEBI:59594

subject_name: Colesevelam

object_name: diarrhea


subject: CHEBI:59594

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:59594

object_name: Diarrhea, CTCAE


subject: CHEBI:59594

object_name: plasma cell myeloma


subject: UNII:B33561JJ61

subject_name: TELAGLENASTAT HYDROCHLORIDE

object_name: Plasma cell myeloma refractory


subject: UNII:B33561JJ61

object_name: Plasma cell myeloma recurrent


subject: UMLS:C5418246

subject_name: Telaglenastat Hydrochloride


subject: UMLS:C5418246


subject: UMLS:C3864309

subject_name: PAPILLOMAVIRUS HUMAN 9-VALENT VACCINE

object_name: Lesion of cervix


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: alcohol abuse


subject: CHEBI:16347

object_name: alcohol dependence


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: HLA-A2 Positive Cells Present


subject: UNII:M89N0Q7EQR

object_name: metastatic malignant neoplasm in the brain


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: Embolism, Tumor


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UMLS:C5564654

object_name: pulmonary eosinophilia


subject: UMLS:C5564654

object_name: Asthmatic pulmonary eosinophilia


subject: PUBCHEM.COMPOUND:122706785

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:122706785

object_name: prostate neoplasm


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: neurotoxicity


subject: CHEBI:72564

subject_name: Temozolomide


subject: DRUGBANK:DB17340

object_name: pancreatic neoplasm


subject: DRUGBANK:DB17340

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB17340

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB17340

object_name: cancer


subject: DRUGBANK:DB17340

object_name: neoplasm


subject: DRUGBANK:DB17340

object_name: melanoma


subject: DRUGBANK:DB17340

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17340

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17340

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:3062

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:3062

object_name: head and neck cancer


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: UNII:4HA45S22ZZ

object_name: colorectal neoplasm


subject: CHEBI:67271


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:149504

object_name: precancerous condition


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:185135

subject_name: Polyvidone

object_name: osteoarthritis


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: malignant peritoneal mesothelioma


subject: UMLS:C3827082


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: Phantom Limb


subject: UNII:2N4O9L084N

object_name: Phantom Limb Pain


subject: UNII:2N4O9L084N

object_name: neuralgia


subject: UNII:2N4O9L084N

object_name: Neuropathic pain


subject: CHEBI:6413

subject_name: Letrozole

object_name: uterine fibroid


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: chronic rhinosinusitis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:73678


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:16108

subject_name: Dihydroxyacetone phosphate

object_name: Plasmodium falciparum malaria


subject: CHEBI:166520

subject_name: Tenamfetamine


subject: CHEBI:32506


subject: CHEBI:566274

subject_name: Malonaldehyde


subject: CHEBI:71019

subject_name: omacetaxine

object_name: FLT3 Internal Tandem Duplication


subject: CHEBI:90217

subject_name: Quizartinib


subject: UMLS:C0354100

subject_name: Loop Diuretics

object_name: Heart failure with normal ejection fraction


subject: CHEBI:77733

subject_name: Verapamil

object_name: Dravet syndrome


subject: CHEBI:77733

object_name: developmental and epileptic encephalopathy, 6A


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:54751657

subject_name: Minocin

object_name: peripheral nervous system disorder


subject: PUBCHEM.COMPOUND:54751657

object_name: neuropathy


subject: PUBCHEM.COMPOUND:54751657

object_name: Acute Pain


subject: PUBCHEM.COMPOUND:54751657

object_name: breast carcinoma


subject: CHEBI:50697

subject_name: minocycline hydrochloride


subject: CHEBI:50697


subject: CHEBI:50697


subject: CHEBI:50697


subject: UMLS:C3248648

subject_name: Injection, minocycline hydrochloride, 1 mg administered


subject: UMLS:C3248648


subject: UMLS:C3248648


subject: UMLS:C3248648


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: PUBCHEM.COMPOUND:54675783


subject: PUBCHEM.COMPOUND:54675783


subject: PUBCHEM.COMPOUND:54675783


subject: CHEBI:15365

subject_name: Aspirin

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: maturity-onset diabetes of the young


subject: PUBCHEM.COMPOUND:155543961

object_name: monogenic diabetes


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C5670500

subject_name: Gefurulimab

object_name: Myasthenia Gravis, Generalized


subject: UMLS:C3658787

object_name: glioblastoma


subject: UMLS:C3658787

object_name: Childhood Glioblastoma


subject: UMLS:C3658787

object_name: adult glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Waldenstrom macroglobulinemia


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: proteinuria


subject: PUBCHEM.COMPOUND:5281767

object_name: Proteinuria of undiagnosed cause


subject: PUBCHEM.COMPOUND:5281767

object_name: Proteinuria, CTCAE 3.0


subject: PUBCHEM.COMPOUND:5281767

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C4688593

object_name: pancreatic neoplasm


subject: UMLS:C4688593

object_name: ovarian cancer


subject: UMLS:C4688593

object_name: ovarian neoplasm


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: cytomegalovirus retinitis


subject: CHEBI:63635

object_name: HIV infection


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: pharyngitis


subject: UMLS:C2348288

object_name: Pharyngalgia


subject: UMLS:C2348288

object_name: Sore Throat, CTCAE


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: Human Papilloma Virus, Female


subject: UMLS:C1512511

object_name: Human Papilloma Virus, Male


subject: UMLS:C1512511


subject: CHEBI:8382

subject_name: Prednisone

object_name: Adenocarcinoma of the prostate stage IV


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Childhood Breast Carcinoma


subject: UNII:71492GE1FX

object_name: breast carcinoma


subject: UNII:71492GE1FX

object_name: breast cancer


subject: CHEBI:31689

subject_name: Iguratimod

object_name: immunoglobulin G4-related sclerosing disease


subject: CHEBI:31689

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Crohn disease


subject: UNII:4B33BGI082

subject_name: Cholestyramine

object_name: kidney failure


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Acute phase response


subject: CHEBI:52717

object_name: survival time


subject: CHEBI:84500

subject_name: varenicline

object_name: cardiovascular disorder


subject: UNII:3BY9Z3M34G

subject_name: Golidocitinib

object_name: small cell carcinoma


subject: UNII:3BY9Z3M34G

object_name: small cell lung carcinoma


subject: UNII:3BY9Z3M34G

object_name: Small cell lung cancer extensive stage


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: IgA Nephropathy


subject: CHEBI:15365

subject_name: Aspirin

object_name: dry eye syndrome


subject: CHEBI:15365

object_name: Dry Eye, CTCAE


subject: CHEBI:15365

object_name: Dryness of eye


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage IIA Lung Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage II Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage IV Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage IIB Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage IVB Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage IVA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage IIIA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:16347

object_name: pulmonary hypertension


subject: CHEBI:16347

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:16347

object_name: pulmonary arterial hypertension


subject: CHEBI:16347

object_name: primary pulmonary hypertension


subject: CHEBI:16347

object_name: heritable pulmonary arterial hypertension


subject: CHEBI:16347

object_name: lung disorder


subject: CHEBI:16347

object_name: Carnitine nutritional deficiency


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: melanoma


subject: UMLS:C4727093

subject_name: dezamizumab

object_name: amyloidosis


subject: CHEBI:135381

subject_name: Trofosfamide

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:135381

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:135381

object_name: sarcoma


subject: CHEBI:135381

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:135381

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:31355

subject_name: Carboplatin

object_name: carcinosarcoma


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: ovarian carcinosarcoma


subject: CHEBI:5864

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:5864

object_name: uterine carcinosarcoma


subject: CHEBI:5864

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:5864

object_name: Recurrent ovarian cancer


subject: CHEBI:5864


subject: CHEBI:5864

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:5864

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:5864

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:5864

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:5864

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:5864

object_name: Stage IIIA Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IIIC Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IIIB Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:5864

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:5864

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:5864

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:5864

object_name: Stage IIB Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IIA Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:5864

object_name: Stage I Ovarian Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:5864

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IB Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IC Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IA Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IVA Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IVB Uterine Sarcoma AJCC v7


subject: CHEBI:5864

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IA Ovarian Cancer


subject: CHEBI:5864

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:5864

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: carcinosarcoma


subject: CHEBI:45863


subject: DRUGBANK:DB05572

object_name: allergic asthma


subject: UMLS:C0701392

subject_name: Nebcin

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:3249

object_name: obesity


subject: PUBCHEM.COMPOUND:3249

object_name: Obesity, CTCAE


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: UMLS:C3714696


subject: UMLS:C3714696


subject: CHEBI:17823

subject_name: Calcitriol

object_name: psoriasis


subject: CHEBI:31547

subject_name: Eplerenone

object_name: chronic kidney disease


subject: CHEBI:31547

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:76842

object_name: Postoperative Complications


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:16296

subject_name: D-Tryptophan

object_name: Parkinson disease


subject: CHEBI:27897

subject_name: tryptophan


subject: CHEBI:29954

subject_name: L-tryptophan residue


subject: CHEBI:95021

subject_name: pemetrexed

object_name: cervical adenosquamous carcinoma


subject: CHEBI:63724


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: arteriosclerosis disorder


subject: CHEBI:8228

object_name: atherosclerosis


subject: CHEBI:78543

subject_name: Ponatinib

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:78543

object_name: lymphoblastic leukemia, acute, with lymphomatous features


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Recurrent tumor


subject: CHEBI:85994

object_name: liver neoplasm


subject: CHEBI:85994

object_name: Adult Liver Carcinoma


subject: UMLS:C1576659

subject_name: banaba leaf extract

object_name: plantar wart


subject: UMLS:C4756531

subject_name: Nitroglycerin only product in oromucosal dose form

object_name: autonomic dysreflexia


subject: UMLS:C4756531

object_name: spinal cord injury


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: hereditary papillary renal cell carcinoma


subject: CHEBI:72317

object_name: Papillary renal cell carcinoma type 2


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: Cardiac amyloidosis


subject: CHEBI:76611

subject_name: flutemetamol


subject: PUBCHEM.COMPOUND:157010259

object_name: Malaria, antepartum


subject: CHEBI:6804

subject_name: Methacholine

object_name: diabetes mellitus


subject: UMLS:C1831747

subject_name: Fenretinide Lipid Matrix

object_name: adult lymphoma


subject: UMLS:C1831747

object_name: lymphoma


subject: UMLS:C1831747

object_name: pediatric lymphoma


subject: UMLS:C1831747

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:137185789

subject_name: 5'-Methyltetrahydrofolic acid

object_name: Pregnant


subject: PUBCHEM.COMPOUND:135483998


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:15641

subject_name: 5-methyltetrahydrofolic acid


subject: CHEBI:6015

subject_name: Isoflurane

object_name: traumatic encephalopathy


subject: CHEBI:6015

object_name: traumatic brain injury


subject: CHEBI:52717

subject_name: Bortezomib

object_name: graft versus host disease


subject: CHEBI:77590

subject_name: Armodafinil

object_name: lung cancer


subject: CHEBI:77590

object_name: lung neoplasm


subject: CHEBI:77590

object_name: lung carcinoma


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: kidney disorder


subject: CHEBI:6503

object_name: inherited disease susceptibility


subject: CHEBI:6503

object_name: Albuminuria


subject: CHEBI:6503

object_name: AIDS


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Acetabular labrum tear


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: UMLS:C1541792

subject_name: Kanglaite Injection

object_name: pancreatic neoplasm


subject: UMLS:C1541792

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1541792

object_name: malignant pancreatic neoplasm


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Malignant neoplasm of stomach stage III


subject: GTOPDB:12989

object_name: Malignant neoplasm of stomach stage II


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: cardiovascular disorder


subject: UNII:83V80O4XY1

object_name: Non STEMI


subject: UNII:83V80O4XY1

object_name: angina unstable


subject: UMLS:C4079957


subject: UMLS:C4079957


subject: UNII:V5Y646AW8S

object_name: psychosis


subject: UNII:V5Y646AW8S

object_name: Psychotic disorder due to a general medical condition


subject: UNII:V5Y646AW8S

object_name: schizoaffective disorder


subject: UNII:V5Y646AW8S

object_name: schizophrenia 18


subject: UNII:V5Y646AW8S

object_name: schizophrenia


subject: UNII:V5Y646AW8S

object_name: schizophreniform disorder


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:8802

subject_name: Remifentanil

object_name: hyperglycemia


subject: CHEBI:8802

object_name: Hyperglycemia, CTCAE


subject: CHEBI:8802

object_name: Glucose in blood specimen above reference range


subject: CHEBI:8802

object_name: heart disorder


subject: CHEBI:114785

subject_name: Erlotinib

object_name: High grade glioma


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:49960

subject_name: Vandetanib


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: West Nile fever


subject: CHEMBL.COMPOUND:CHEMBL1743018

subject_name: FICLATUZUMAB

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: malignant pancreatic neoplasm


subject: UMLS:C2703138

subject_name: ficlatuzumab


subject: UMLS:C2703138


subject: UMLS:C2703138


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: prostate neoplasm


subject: UNII:4T36H88UA7

object_name: Disseminated Malignant Neoplasm


subject: UNII:4T36H88UA7

object_name: Embolism, Tumor


subject: UNII:4T36H88UA7

object_name: Neoplasm Metastasis


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:68534


subject: CHEBI:68534


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: UMLS:C5206815

object_name: cervical squamous cell carcinoma


subject: UMLS:C5206815

object_name: cervical adenocarcinoma


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Leptomeningeal Neoplasms


subject: UNII:K16AIQ8CTM

object_name: neoplastic meningitis


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: DRUGBANK:DB16538

subject_name: Bifidobacterium bifidum

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: abdominal aortic aneurysm


subject: UNII:LKC0U3A8NJ

object_name: aortic aneurysm, familial abdominal, 1


subject: UMLS:C5187976

subject_name: birch pollen allergen extract

object_name: atopic conjunctivitis


subject: UMLS:C5187976

object_name: Atopic rhinitis


subject: UMLS:C5187976

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C5187976

object_name: Hay fever


subject: UMLS:C5187976

object_name: Allergy


subject: UMLS:C5187976

object_name: hypersensitivity reaction disease


subject: UMLS:C5187976

object_name: Emotional hypersensitivity


subject: CHEBI:52717

subject_name: Bortezomib

object_name: ovarian cancer


subject: CHEBI:52717

object_name: ovarian neoplasm


subject: CHEBI:52717

object_name: ovarian carcinoma


subject: CHEBI:7582

subject_name: Nitrendipine

object_name: hypertension


subject: CHEBI:7582

object_name: Hypertension, CTCAE


subject: CHEBI:8863

subject_name: Riluzole

object_name: Ataxia


subject: CHEBI:8863

object_name: aceruloplasminemia


subject: CHEBI:8863

object_name: multiple sclerosis


subject: CHEBI:8863

object_name: hereditary ataxia


subject: MESH:C570356

subject_name: SBR 759

object_name: chronic kidney disease


subject: MESH:C570356

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:8R4A7GDZ1D

subject_name: Apabetalone


subject: UNII:H8MTN7XVC2

subject_name: Mitometh

object_name: esophageal squamous cell carcinoma


subject: PR:000029794

subject_name: mitochondrial import inner membrane translocase subunit Tim8 A


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:63450

subject_name: Masitinib

object_name: plasma cell myeloma


subject: UMLS:C2351399


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Ovarian cancer stage IV


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:76842

object_name: staphylococcal infection


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Cystic acne


subject: UMLS:C0592073

subject_name: Roaccutane


subject: CHEBI:18361

object_name: coronary artery disorder


subject: CHEBI:18361

object_name: coronary atherosclerosis


subject: CHEBI:18361

object_name: myocardial infarction


subject: CHEBI:18361

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:18361

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:53266

subject_name: poly(propylene imine) macromolecule


subject: CHEBI:53266


subject: CHEBI:53266


subject: CHEBI:53266


subject: CHEBI:53266


subject: CHEBI:35782

subject_name: diphosphate ion


subject: CHEBI:35782


subject: CHEBI:35782


subject: CHEBI:35782


subject: CHEBI:35782


subject: CHEBI:60614

subject_name: poly(propylene imine) polymer


subject: CHEBI:60614


subject: CHEBI:60614


subject: CHEBI:60614


subject: CHEBI:60614


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: CHEBI:29888


subject: CHEBI:29888


subject: CHEBI:29888


subject: CHEBI:29888


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:49900

object_name: Adult Gliosarcoma


subject: CHEBI:49900

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:32660

subject_name: asparaginase

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:94265

subject_name: Cerubidin

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:63612

subject_name: Nelarabine


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: CHEBI:4911

subject_name: Etoposide

object_name: pediatric intraocular retinoblastoma


subject: CHEBI:4911

object_name: intraocular retinoblastoma


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Wound Infection


subject: CHEBI:25805

object_name: Wound Infection, CTCAE


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:6121

subject_name: Ketamine

object_name: Neuropathic pain


subject: CHEBI:142552

subject_name: rac-tamsulosin

object_name: Ureteral Calculi


subject: CHEBI:142552

object_name: ureterolithiasis


subject: CHEBI:142548

subject_name: ent-tamsulosin


subject: CHEBI:142548


subject: UNII:K3M925R42M

object_name: pancreatic ductal adenocarcinoma


subject: UNII:K3M925R42M

object_name: non-small cell lung carcinoma


subject: UNII:K3M925R42M

object_name: colorectal neoplasm


subject: UMLS:C5555061

subject_name: SHP2 Inhibitor PF-07284892


subject: UMLS:C5555061


subject: UMLS:C5555061


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB


subject: MESH:D008458

subject_name: Measles Vaccine

object_name: Japanese encephalitis


subject: MESH:D009108

subject_name: Mumps Vaccine


subject: CHEBI:149509

object_name: peripheral nervous system disorder


subject: CHEBI:149509

object_name: neuropathy


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:83531

subject_name: Moclobemide

object_name: nicotine dependence


subject: CHEBI:55312

subject_name: diphenylmethane monoisocyanate

object_name: Advanced cancer


subject: CHEBI:35255

subject_name: Chloroform

object_name: colorectal cancer


subject: CHEBI:35255

object_name: colorectal carcinoma


subject: CHEBI:35255

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:33392

subject_name: Californium


subject: CHEBI:33392


subject: CHEBI:33392


subject: CHEBI:187893

subject_name: Baclofen

object_name: liver carcinoma


subject: PR:000034060

subject_name: granzyme B(G,H)


subject: PR:000003848

subject_name: cytosolic carboxypeptidase 1


subject: CHEBI:8499

subject_name: Propranolol

object_name: cerebral cavernous malformation


subject: CHEBI:50730

subject_name: Montelukast

object_name: Upper Respiratory Infections


subject: CHEBI:50730

object_name: Upper Respiratory Infection, CTCAE


subject: UMLS:C3883356

subject_name: Lipid Emulsion

object_name: Pesticide poisoning


subject: GTOPDB:12989

subject_name: toripalimab

object_name: non-small cell squamous lung carcinoma


subject: GTOPDB:12989

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C5556710

subject_name: EGFR/EGFRvIII Inhibitor CM93

object_name: glioblastoma


subject: UMLS:C5556710

object_name: Childhood Glioblastoma


subject: UMLS:C5556710

object_name: adult glioblastoma


subject: UMLS:C3537195

subject_name: Cannabis-Based Oromucosal Spray GW-1000-02

object_name: multiple sclerosis


subject: UMLS:C3274746

subject_name: PVS-RIPO


subject: UMLS:C3274746


subject: UMLS:C3274746


subject: UMLS:C3274746

object_name: glioma


subject: UNII:3UAA36FHF1

object_name: neuralgia


subject: UNII:3UAA36FHF1

object_name: Neuropathic pain


subject: DRUGBANK:DB19004


subject: DRUGBANK:DB19004


subject: CHEBI:90237

subject_name: Tandutinib


subject: CHEBI:90237

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:90237

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:90237

object_name: brain cancer


subject: CHEBI:90237

object_name: Adult Gliosarcoma


subject: UMLS:C5139926

object_name: Parainfluenza Virus Infections


subject: UMLS:C5139926

object_name: Parainfluenza


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: pancreatic neoplasm


subject: GTOPDB:13085

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:13085

object_name: malignant pancreatic neoplasm


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C3179444

object_name: Cicatrization


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Relapsed/refractory multiple myeloma


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:CO86AOP337

subject_name: ETENTAMIG


subject: UMLS:C5236471


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: phenylketonuria


subject: CHEBI:36005

object_name: classic phenylketonuria


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: PUBCHEM.COMPOUND:66586232

object_name: staphylococcus aureus infection


subject: PUBCHEM.COMPOUND:66586232

object_name: Staphylococcal Skin Infections


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent ovarian cancer


subject: UMLS:C4733610

object_name: Advanced cancer


subject: CHEBI:5613

subject_name: Haloperidol

object_name: type 2 diabetes mellitus


subject: CHEBI:5613

object_name: Insulin resistance


subject: CHEBI:5613

object_name: inherited lipid metabolism disorder


subject: CHEBI:5613

object_name: Dyslipidemia


subject: CHEBI:77590

subject_name: Armodafinil

object_name: schizophrenia


subject: CHEBI:31859

subject_name: Modafinil


subject: UNII:08WG8S0L8D

object_name: esophageal adenocarcinoma


subject: UNII:08WG8S0L8D

object_name: Gastric Mixed Adenocarcinoma


subject: UNII:08WG8S0L8D

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UNII:08WG8S0L8D

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UNII:08WG8S0L8D

object_name: stage IV esophageal cancer


subject: UNII:08WG8S0L8D

object_name: gastric intestinal type adenocarcinoma


subject: UNII:08WG8S0L8D

object_name: diffuse gastric adenocarcinoma


subject: UNII:08WG8S0L8D

object_name: stage IIIC esophageal cancer


subject: UNII:08WG8S0L8D

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: UNII:08WG8S0L8D

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: UNII:08WG8S0L8D

object_name: stage IIIA esophageal cancer


subject: UNII:08WG8S0L8D

object_name: stage IIIB esophageal cancer


subject: UNII:08WG8S0L8D

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: UNII:08WG8S0L8D


subject: UNII:08WG8S0L8D

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:08WG8S0L8D

object_name: Stage IIIA Gastric Carcinoma


subject: UNII:08WG8S0L8D

object_name: Stage IIIB Gastric Carcinoma


subject: UNII:08WG8S0L8D

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: UNII:08WG8S0L8D

object_name: digestive system cancer


subject: UNII:N7T15V1FUY

subject_name: Setmelanotide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:N7T15V1FUY

object_name: obesity


subject: UNII:N7T15V1FUY

object_name: Obesity, CTCAE


subject: UNII:N7T15V1FUY

object_name: Prader-Willi syndrome


subject: UNII:N7T15V1FUY

object_name: Polyphagia


subject: CHEBI:6801

subject_name: Metformin

object_name: long COVID-19


subject: CHEBI:9150

subject_name: Simvastatin

object_name: chronic pancreatitis


subject: CHEBI:9150

object_name: Recurrent pancreatitis


subject: UMLS:C1513261

subject_name: Micellar Paclitaxel

object_name: psoriasis


subject: UMLS:C5907979

subject_name: Base Edited Natural Killer Cells NK510

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5907979

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5907979

object_name: sarcoma


subject: UMLS:C5907979

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5907979

object_name: soft tissue sarcoma


subject: UMLS:C5907979

object_name: pediatric osteosarcoma


subject: UMLS:C5907979

object_name: Osteosarcoma


subject: UMLS:C5706427

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: abdominal aortic aneurysm


subject: CHEBI:68558

object_name: aortic aneurysm, familial abdominal, 1


subject: CHEBI:194425

subject_name: Lobaplatin

object_name: triple-negative breast carcinoma


subject: CHEBI:194425

object_name: Triple-Negative Breast Cancer Finding


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: CHEBI:192744


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DPT0O3T46P

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:DPT0O3T46P

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:50634

object_name: Heart Failure, CTCAE


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:31905

subject_name: Nicorandil

object_name: No-Reflow Phenomenon


subject: UMLS:C0962969

subject_name: RAD 001

object_name: lung neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: metastatic colorectal cancer


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Surgical procedure finding


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:74030550


subject: CHEBI:7476

subject_name: Naproxen

object_name: sleep disorder


subject: CHEBI:7476

object_name: bruxism


subject: CHEBI:7476

object_name: hypertension


subject: CHEBI:7476

object_name: Hypertension, CTCAE


subject: CHEBI:7476

object_name: sleep apnea


subject: CHEBI:7476

object_name: Sleep Apnea, CTCAE


subject: CHEBI:7476

object_name: Heart Disease Risk Factors


subject: CHEBI:7476

object_name: cardiovascular disorder


subject: CHEBI:7476

object_name: Mental Status Change


subject: CHEBI:7476

object_name: Thyroid dysfunction


subject: CHEBI:7476

object_name: temporomandibular joint disorder


subject: CHEBI:94614

subject_name: Opipramol


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: UMLS:C3827163

subject_name: Cusatuzumab

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Nasal congestion


subject: CHEBI:74327

subject_name: Ile-Val


subject: UNII:DM9UIR23R7

object_name: adult lymphoma


subject: UNII:DM9UIR23R7

object_name: lymphoma


subject: UNII:DM9UIR23R7

object_name: pediatric lymphoma


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: acute lung injury


subject: CHEBI:73604

object_name: bronchopulmonary dysplasia


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: digestive system neoplasm


subject: MESH:C079198

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: congenital heart disease


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:57694

object_name: osteoarthritis


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:232408

subject_name: Racemetyrosine

object_name: cocaine dependence


subject: CHEBI:6912

subject_name: Metyrosine


subject: UMLS:C0051427

subject_name: Demser


subject: CHEBI:6887

subject_name: Methylphenidate


subject: UMLS:C5783513

subject_name: Acetylglucosaminyltransferase V Inhibitor PhOx430

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5783513

object_name: cancer


subject: UMLS:C5783513

object_name: glioblastoma


subject: UMLS:C5783513

object_name: Brain Stem Glioblastoma


subject: UMLS:C5783513

object_name: glioma susceptibility 1


subject: UMLS:C5783513

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5783513

object_name: Embolism, Tumor


subject: UMLS:C5783513

object_name: Neoplasm Metastasis


subject: DRUGBANK:DB17317

subject_name: Belzupacap Sarotalocan

object_name: choroidal melanoma


subject: DRUGBANK:DB17317

object_name: uveal melanoma


subject: DRUGBANK:DB17317

object_name: malignant choroid melanoma


subject: DRUGBANK:DB17317

object_name: ocular melanoma


subject: UMLS:C4527301

subject_name: Human papillomavirus virus-like particles conjugated with ir700 dye au-011


subject: UMLS:C4527301


subject: UMLS:C4527301


subject: UMLS:C4527301


subject: CHEBI:87681

subject_name: Ranolazine

object_name: atrial fibrillation new onset


subject: CHEBI:87681

object_name: complications; medical care, late effect of complications


subject: CHEBI:87681

object_name: ventricular tachycardia


subject: CHEBI:87681

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: CHEBI:87681

object_name: continuous electrocardiogram ventricular tachycardia


subject: CHEBI:87681

object_name: Ventricular Tachycardia by ECG Finding


subject: CHEBI:87681

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: CHEBI:87681

object_name: Prolonged QTc Interval, CTCAE


subject: CHEBI:87681

object_name: Prolonged QTc interval


subject: CHEBI:87681

object_name: Hemorrhage


subject: UMLS:C5854667

object_name: pancreatic ductal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594461

subject_name: AUTOLOGOUS CORD BLOOD

object_name: stroke disorder


subject: CHEMBL.COMPOUND:CHEMBL4594461

object_name: cerebral infarction


subject: CHEMBL.COMPOUND:CHEMBL4594461

object_name: cerebrovascular disorder


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:11332179

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:11332179

object_name: thyroid cancer


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: atopic eczema


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate

object_name: Out-of-Hospital Cardiac Arrest


subject: UMLS:C0876183

subject_name: Thyrogen


subject: UMLS:C0876183


subject: UMLS:C0876183


subject: UMLS:C5446566

subject_name: B-cell Lymphoma-2 Inhibitor BGB-11417

object_name: Waldenstrom macroglobulinemia


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033

object_name: end stage renal failure


subject: CHEBI:10033

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: Immunocompromised Host


subject: PUBCHEM.COMPOUND:78357831

object_name: cancer


subject: PUBCHEM.COMPOUND:78357831

object_name: neoplasm


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Frailty


subject: CHEBI:4806

object_name: Inflammation


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: ulcerative colitis


subject: UNII:CUJ2MVI71Y

object_name: inflammatory bowel disease 1


subject: UNII:CUJ2MVI71Y

object_name: inflammatory bowel disease


subject: UNII:CUJ2MVI71Y

object_name: digestive system disorder


subject: UNII:CUJ2MVI71Y

object_name: gastrointestinal disease


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: UNII:CI43QFE22O

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:155586901


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine

object_name: multiple sclerosis


subject: UMLS:C0305065

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0305062


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Myelodysplasia


subject: CHEBI:44423

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:44423

object_name: myoclonic dystonia 11


subject: PUBCHEM.COMPOUND:154618785

subject_name: Ritivixibat

object_name: sclerosing cholangitis


subject: PUBCHEM.COMPOUND:154618785

object_name: primary sclerosing cholangitis


subject: UNII:3U7H6NE2KE

subject_name: RITIVIXIBAT


subject: UNII:3U7H6NE2KE


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: colorectal carcinoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: colorectal cancer


subject: UMLS:C0013227


subject: UMLS:C0013227

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Osteopenia


subject: UMLS:C2987383

object_name: Stomach cancer


subject: UMLS:C2987383

object_name: gastric cancer


subject: UMLS:C0722517

subject_name: Pedialyte

object_name: gastroenteritis


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Hormone sensitive prostate cancer


subject: CHEBI:30742

subject_name: macrogol

object_name: Gender Dysphoria


subject: CHEBI:30742

object_name: gender incongruence


subject: UNII:G8WSM7R635

subject_name: Tirasemtiv

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:G8WSM7R635

object_name: amyotrophic lateral sclerosis


subject: UNII:UY3TW7VRW9

subject_name: RUXOLITINIB, (+/-)-


subject: CHEBI:63610

subject_name: Misoprostol

object_name: fetus affected by Cesarean delivery


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:4026

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4026

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4026

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4026

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4026

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:4026

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:4026

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:4026

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:4026

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:4027

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:4027

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:4027

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4027

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4027

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4027

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4027

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4027

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:4027

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:4027

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:4027

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:4027

object_name: Stage IV Adult Burkitt Lymphoma


subject: GTOPDB:4934

subject_name: G-CSF

object_name: myocardial infarction


subject: GTOPDB:4934

object_name: Myocardial Infarction, CTCAE


subject: GTOPDB:4934

object_name: Myocardial Infarction by ECG Finding


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:147894286

subject_name: VOTOPLAM

object_name: Huntington disease


subject: UNII:D7EZ7B585X


subject: UMLS:C5909105

subject_name: Votoplam


subject: UNII:1000BJC8CR

subject_name: TRASTUZUMAB REZETECAN

object_name: Childhood Breast Carcinoma


subject: UNII:1000BJC8CR

object_name: breast carcinoma


subject: UNII:1000BJC8CR

object_name: breast cancer


subject: CHEBI:4875

subject_name: Etanercept

object_name: graft versus host disease


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: MESH:C000625147


subject: MESH:C000625147


subject: MESH:C000625147


subject: CHEBI:4910

subject_name: Etomidate

object_name: Physical trauma


subject: CHEBI:4910

object_name: Injury


subject: CHEBI:4910

object_name: Trauma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: DNA Damage Response Gene Mutation


subject: UMLS:C2346820


subject: UNII:2AW48LAZ4I

subject_name: IMETELSTAT SODIUM

object_name: myelofibrosis


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:3139

subject_name: bleomycin

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:3139

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:36373

subject_name: vindesine


subject: CHEBI:36373


subject: CHEBI:27666

subject_name: Dactinomycin

object_name: hydatidiform mole, recurrent, 1


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: schizoaffective disorder


subject: CHEBI:16581

object_name: schizophrenia 18


subject: CHEBI:17394

subject_name: Theanine

object_name: schizophrenia


subject: CHEBI:17394


subject: CHEBI:17394


subject: UMLS:C0076380

subject_name: theanine


subject: UMLS:C0076380


subject: UMLS:C0076380


subject: PUBCHEM.COMPOUND:72821915

subject_name: Seocalcitol

object_name: liver neoplasm


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: Nonulcer dyspepsia


subject: CHEBI:53762

object_name: sleep disorder, initiating and maintaining sleep


subject: CHEBI:32315

subject_name: Zopiclone


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Infection of heart transplant


subject: CHEBI:49040

object_name: lung transplant infection


subject: CHEBI:49040

object_name: Infection of transplanted kidney


subject: CHEBI:8884

subject_name: Rocuronium

object_name: congenital alveolar dysplasia


subject: CHEBI:8884

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:8884

object_name: adult acute respiratory distress syndrome


subject: CHEBI:8884

object_name: newborn respiratory distress syndrome


subject: UMLS:C4547381

object_name: candidiasis, invasive


subject: UMLS:C4547381

object_name: candidiasis


subject: UMLS:C4547381

object_name: candidemia


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: lung cancer


subject: MESH:C520255

object_name: lung neoplasm


subject: MESH:C520255

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: cardiovascular disorder


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:23359

subject_name: colchicine

object_name: Pericardial Effusion Related to COVID-19


subject: CHEBI:23359

object_name: pericardial effusion


subject: CHEBI:23359

object_name: Pericardial Effusion, CTCAE


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: nervous system disorder


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:49668

subject_name: Gefitinib

object_name: brain cancer


subject: CHEBI:49668

object_name: brain neoplasm


subject: PUBCHEM.COMPOUND:13444038

subject_name: Sugemalimab


subject: PUBCHEM.COMPOUND:13444038


subject: PUBCHEM.COMPOUND:13444038


subject: GTOPDB:12342

subject_name: sugemalimab


subject: GTOPDB:12342


subject: GTOPDB:12342


subject: CHEMBL.COMPOUND:CHEMBL4594535

subject_name: SUGEMALIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594535


subject: CHEMBL.COMPOUND:CHEMBL4594535


subject: UMLS:C4733610


subject: UMLS:C4733610


subject: UMLS:C4733610


subject: CHEBI:85978

subject_name: Isavuconazonium

object_name: invasive aspergillosis


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage IV Renal Cell Cancer


subject: UNII:M89N0Q7EQR

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Renal cell carcinoma recurrent


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:44241

subject_name: Metyrapone

object_name: cocaine abuse


subject: CHEBI:29033

subject_name: Ferrous cation


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: nonpapillary renal cell carcinoma


subject: UNII:9AG41L3AOQ

object_name: clear cell renal carcinoma


subject: UNII:9AG41L3AOQ

object_name: renal cell adenocarcinoma


subject: UNII:9AG41L3AOQ

object_name: renal cell carcinoma


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: autosomal dominant hypocalcemia


subject: CHEBI:89324

object_name: Hypocalcemia


subject: CHEBI:89324

object_name: Serum calcium below normal (finding)


subject: CHEBI:89324

object_name: Hypocalcemia, CTCAE


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Labor Pain


subject: CHEBI:3215

subject_name: Bupivacaine


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: liver cancer


subject: PUBCHEM.COMPOUND:139350422

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:139350422

object_name: Adult Liver Carcinoma


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UMLS:C3658638

object_name: prostate adenocarcinoma


subject: PUBCHEM.COMPOUND:155885731

subject_name: Maribavir

object_name: Complication of transplant


subject: CHEBI:681569

subject_name: Clofarabine

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:681569

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:681569


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: aortic dissection


subject: CHEBI:6888

object_name: Aortic dissection


subject: UMLS:C0796627

subject_name: Iomab-B

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0796627

object_name: acute myeloid leukemia


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: bronchiectasis


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: MESH:C541436

subject_name: calcipex II

object_name: chronic apical periodontitis


subject: MESH:C498115

subject_name: Metapex


subject: UMLS:C3896927

object_name: non-Hodgkin lymphoma


subject: UMLS:C3896927

object_name: plasma cell myeloma


subject: UMLS:C3896927

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C3896927

object_name: B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: PUBCHEM.COMPOUND:71226663


subject: UNII:YK5DTP8NHU

object_name: pancreatic adenocarcinoma


subject: UNII:YK5DTP8NHU

object_name: cervical adenosquamous carcinoma


subject: UNII:YK5DTP8NHU

object_name: pancreatic adenosquamous carcinoma


subject: UNII:YK5DTP8NHU

object_name: adenosquamous carcinoma


subject: UNII:YK5DTP8NHU

object_name: prostate neuroendocrine neoplasm


subject: UNII:YK5DTP8NHU

object_name: Neuroendocrine carcinoma of prostate


subject: UNII:YK5DTP8NHU

object_name: pancreatic endocrine carcinoma


subject: UNII:YK5DTP8NHU

object_name: Neuroendocrine carcinoma of pancreas


subject: UNII:YK5DTP8NHU

object_name: pancreatic neuroendocrine tumor


subject: UNII:YK5DTP8NHU

object_name: Neuroendocrine tumor of pancreas


subject: UNII:YK5DTP8NHU


subject: UNII:YK5DTP8NHU

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: UMLS:C2830064


subject: CHEBI:24859

subject_name: iodine atom

object_name: Iodine deficiency


subject: CHEBI:17606

subject_name: Iodine


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: CHEBI:231350

subject_name: Pacritinib

object_name: chronic myelomonocytic leukemia


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: macular degeneration


subject: CHEBI:68646

object_name: age-related macular degeneration


subject: CHEBI:68646

object_name: retinitis pigmentosa 30


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: UMLS:C2703114


subject: UMLS:C2703114


subject: UMLS:C2703114


subject: CHEBI:6801

subject_name: Metformin

object_name: Post traumatic osteoarthritis


subject: CHEBI:6801

object_name: osteoarthritis, knee


subject: CHEBI:6801

object_name: Anterior Cruciate Ligament Tear


subject: CHEBI:24814

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1705207

subject_name: Endostar

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:2735

object_name: bipolar depression


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41


subject: CHEBI:137064

subject_name: Galunisertib

object_name: liver carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Astrocytoma


subject: CHEBI:8988


subject: CHEBI:8988

object_name: astrocytic tumor


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: UMLS:C4317277

object_name: HIV infection


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: nephrotoxicity


subject: CHEBI:7773

subject_name: Ondansetron


subject: UNII:YZS3R7LP44

subject_name: Palonosetron


subject: UMLS:C5785431

subject_name: ATX Inhibitor IOA-289

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Extreme immaturity


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:91397

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:91397

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C5399992

object_name: essential thrombocythemia


subject: UMLS:C5399992

object_name: acquired polycythemia vera


subject: UMLS:C5399992

object_name: myelofibrosis


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Estrogen Receptor Negative


subject: CHEBI:63587

subject_name: Eribulin


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:70789204

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: HER2/Neu Negative


subject: UMLS:C5418082

object_name: Childhood Solid Neoplasm


subject: UMLS:C5418082

object_name: Adult Solid Neoplasm


subject: UMLS:C5418082

object_name: Solid Neoplasm


subject: UMLS:C2699717

subject_name: Sulfate-Based Laxative BLI850

object_name: colon carcinoma


subject: UMLS:C2699717

object_name: colorectal cancer


subject: UMLS:C2699717

object_name: colon cancer


subject: UMLS:C0042210

subject_name: Vaccines

object_name: western equine encephalitis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:15365

subject_name: Aspirin

object_name: fetal growth restriction


subject: CHEBI:15365

object_name: Fetal Growth Retardation, CTCAE


subject: CHEBI:46195

object_name: Fractured


subject: UMLS:C2917659


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C4705188

object_name: Medication interaction potentiation


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UMLS:C5706549

subject_name: Anti-PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363

object_name: melanoma


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: inherited lipid metabolism disorder


subject: PUBCHEM.COMPOUND:2735

object_name: Abdominal obesity


subject: PUBCHEM.COMPOUND:2735

object_name: hypertension


subject: PUBCHEM.COMPOUND:2735

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: chronic kidney disease


subject: CHEBI:68558

object_name: Chronic uremia


subject: CHEBI:30089

subject_name: Acetate

object_name: mixed anxiety and depressive disorder


subject: CHEBI:47622

subject_name: acetate ester


subject: CHEBI:40410

subject_name: N-acetylglycine


subject: CHEBI:15366

subject_name: Acetic acid


subject: CHEBI:52051

subject_name: benzyl acetate


subject: DRUGBANK:DB16596

subject_name: Apple cider vinegar


subject: CHEBI:15365

object_name: thrombocytopenic purpura


subject: UMLS:C1517908

subject_name: DepoCyte

object_name: acute lymphoblastic leukemia


subject: CHEBI:36791

subject_name: Escitalopram

object_name: stroke disorder


subject: CHEBI:36791

object_name: cerebrovascular disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Acute myeloid leukemia in remission


subject: PUBCHEM.COMPOUND:1805

object_name: Treatment related acute myeloid leukaemia


subject: PUBCHEM.COMPOUND:1805

object_name: hematologic disorder


subject: PUBCHEM.COMPOUND:1805

object_name: Measurable Residual Disease Persistence


subject: PUBCHEM.COMPOUND:1805

object_name: FLT3 gene mutation


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: sarcoma


subject: PUBCHEM.COMPOUND:135449332

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:135449332

object_name: pediatric osteosarcoma


subject: PUBCHEM.COMPOUND:135449332

object_name: Osteosarcoma


subject: PUBCHEM.COMPOUND:135449332

object_name: connective and soft tissue neoplasm


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: plantar fasciitis


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: sexually transmitted disease


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:74981710

subject_name: Bromelain

object_name: Malocclusion


subject: UMLS:C0006217

subject_name: bromelains


subject: UMLS:C0293742

subject_name: stem bromelain


subject: CHEBI:4975

subject_name: Famotidine

object_name: sickle cell disease


subject: CHEBI:8988

object_name: peritoneum cancer


subject: UMLS:C2352201

subject_name: Conbercept

object_name: diabetic macular edema


subject: CHEBI:135779

subject_name: Amrubicin

object_name: Small cell lung cancer extensive stage


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEBI:145371

subject_name: Binimetinib

object_name: nervous system cancer


subject: CHEBI:145371

object_name: brain neoplasm


subject: CHEBI:145371

object_name: primary brain neoplasm


subject: CHEBI:6931

subject_name: Midazolam

object_name: melanoma


subject: CHEBI:6931

object_name: cancer


subject: CHEBI:6931


subject: CHEBI:6931

object_name: brain cancer


subject: CHEBI:6931


subject: CHEBI:6931


subject: MESH:C000730997


subject: MESH:C000730997


subject: MESH:C000730997


subject: MESH:C000730997


subject: MESH:C000730997


subject: MESH:C000730997


subject: MESH:C000730997

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:58008990

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:58008990

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:58008990

object_name: B-cell small lymphocytic lymphoma refractory


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Depressed mood


subject: UMLS:C5543926


subject: UMLS:C4329321

object_name: glioma


subject: UMLS:C4329321

object_name: malignant glioma


subject: UNII:45II35329V

subject_name: Setanaxib

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:18459832

subject_name: Finafloxacin

object_name: Helicobacter pylori infectious disease


subject: PUBCHEM.COMPOUND:18459832

object_name: gram-negative bacterial infections


subject: PUBCHEM.COMPOUND:18459832

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:18459832

object_name: Dyspepsia, CTCAE


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: CHEBI:51254


subject: CHEBI:51254


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: frozen shoulder


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: adrenal carcinoma


subject: CHEBI:45863

object_name: adrenal cortex carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:77260

object_name: cystic fibrosis


subject: CHEBI:77260

object_name: exocrine pancreatic insufficiency


subject: CHEBI:44915

subject_name: Propofol

object_name: sleep disorder


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: endometrial carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: PUBCHEM.COMPOUND:3021749

object_name: lung disorder


subject: PUBCHEM.COMPOUND:3021749

object_name: obstructive lung disease


subject: UNII:GR88G0I6UL

subject_name: IPRATROPIUM


subject: UNII:GR88G0I6UL


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: PUBCHEM.COMPOUND:657309


subject: CHEBI:176334

object_name: small cell carcinoma


subject: MESH:C086631

subject_name: mineral trioxide aggregate

object_name: dental pulp disorder


subject: MESH:C086631

object_name: tooth disorder


subject: MESH:C086631

object_name: pulpitis


subject: UMLS:C5396052

subject_name: Inactivated whole Hepatitis A virus antigen only vaccine product

object_name: hepatitis A vaccine (history)


subject: UNII:S5NN2E9ZKF

subject_name: DOTMP SM-153

object_name: Bone Pain, CTCAE 3.0


subject: UNII:S5NN2E9ZKF

object_name: Bone pain


subject: UNII:S5NN2E9ZKF

object_name: Bone Pain, CTCAE 5.0


subject: GTOPDB:12990

subject_name: sintilimab

object_name: primary central nervous system lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: Overweight


subject: CHEBI:161680

subject_name: Aztreonam

object_name: HIV infection


subject: UNII:PKT9732S5K

object_name: malaria


subject: UNII:4K7VT5621X

subject_name: AQ-13 free base


subject: CHEMBL.COMPOUND:CHEMBL4297695


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: cannabis abuse


subject: CHEBI:231369

subject_name: Savolitinib

object_name: neoplasm


subject: UMLS:C3641856


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Vasoplegia


subject: PUBCHEM.COMPOUND:70789201

subject_name: Telithromycin

object_name: maxillary sinusitis


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Weight Change


subject: UMLS:C0591784

subject_name: Microgynon 30


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: Compulsion


subject: CHEBI:44915

subject_name: Propofol

object_name: Sepsis


subject: CHEBI:44915

object_name: Sepsis, CTCAE


subject: CHEBI:44915

object_name: Shock


subject: CHEBI:16822

subject_name: choline sulfate

object_name: Exertional rhabdomyolysis (disorder)


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:230492

object_name: Alzheimer disease type 1


subject: CHEBI:230492

object_name: Alzheimer disease


subject: CHEBI:41423

subject_name: Celecoxib

object_name: colorectal adenoma


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: inflammatory bowel disease 1


subject: CHEBI:76842

object_name: biliary atresia


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: Pain Relief


subject: CHEBI:31905

subject_name: Nicorandil

object_name: heart failure


subject: CHEBI:31905

object_name: congestive heart failure


subject: CHEBI:45783

subject_name: Imatinib

object_name: essential thrombocythemia


subject: CHEBI:45783

object_name: myelofibrosis


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: DRUGBANK:DB15806

subject_name: CoronaVac

object_name: Rheumatism


subject: DRUGBANK:DB15806

object_name: AIDS


subject: DRUGBANK:DB15806

object_name: HIV infection


subject: DRUGBANK:DB15806

object_name: Safety Issues


subject: CHEBI:30879

subject_name: alcohol

object_name: alcoholic liver diseases


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:8863

subject_name: Riluzole

object_name: endogenous depression


subject: CHEBI:8863

object_name: major depressive disorder


subject: CHEBI:4469

subject_name: dexamfetamine

object_name: schizophrenia


subject: CHEBI:4469

object_name: Sensitization (disorder)


subject: CHEBI:4469

object_name: psychosis


subject: CHEBI:4469

object_name: Nonorganic psychosis


subject: CHEBI:4469

object_name: Psychosis, CTCAE


subject: CHEBI:74061

subject_name: Ile-Arg

object_name: Hepatic impairment


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: CHEBI:82978

subject_name: paliperidone


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:71952

subject_name: Dactolisib

object_name: castration-resistant prostate carcinoma


subject: UMLS:C2347425


subject: CHEBI:71954

subject_name: Buparlisib


subject: CHEBI:40279

subject_name: Allopurinol

object_name: sarcopenia


subject: CHEBI:8382

subject_name: Prednisone

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396

object_name: Autoimmunity


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:51209

subject_name: Pseudoephedrine

object_name: rhinitis


subject: CHEBI:51209

object_name: atopy


subject: CHEBI:33283

subject_name: THIAMINE

object_name: primary biliary cholangitis


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: primary progressive multiple sclerosis


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: lymphedema


subject: CHEBI:60648

object_name: Lymphedema, CTCAE


subject: CHEBI:60648

object_name: filariasis


subject: CHEBI:60648

object_name: Infection by Filaroides


subject: CHEBI:60648

object_name: filarial elephantiasis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: DRUGBANK:DB17931

subject_name: Engensis

object_name: Diabetic Neuralgia


subject: CHEBI:40303

subject_name: Lovastatin

object_name: Drug Resistant Epilepsy


subject: CHEBI:40303

object_name: temporal lobe epilepsy


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: Plasmodium falciparum malaria


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: malignant neoplasm of breast stage I


subject: UNII:DPT0O3T46P

object_name: breast carcinoma in situ


subject: UMLS:C4278128

subject_name: subetta

object_name: type 2 diabetes mellitus


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Sleep Quality


subject: CHEBI:4466

object_name: Senility


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:60799

subject_name: Esketamine


subject: CHEBI:60799


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:231598

object_name: B-cell neoplasm


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Pain, Intractable


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: cesarean section; complications


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Head and Neck Carcinoma of Unknown Primary


subject: PUBCHEM.COMPOUND:2767

object_name: Locally Advanced Oral Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Locally Advanced Laryngeal Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Locally Advanced Nasal Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Locally Advanced Hypopharyngeal Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Locally Advanced Paranasal Sinus Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Locally Advanced Oropharyngeal Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Laryngeal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: maxillary sinus squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Head and Neck Carcinoma of Unknown Primary


subject: CHEBI:95089

object_name: Locally Advanced Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Locally Advanced Laryngeal Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Locally Advanced Sinonasal Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Locally Advanced Nasal Cavity Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Locally Advanced Hypopharyngeal Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Locally Advanced Paranasal Sinus Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Locally Advanced Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: CHEBI:95089

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:95089

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:95089

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:95089

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:95089

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:95089

object_name: maxillary sinus squamous cell carcinoma


subject: CHEBI:95089

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:95089

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

subject_name: Celecoxib

object_name: uterine cancer


subject: CHEBI:41423

object_name: tumor of uterus


subject: CHEBI:16664

subject_name: Albendazole

object_name: onchocerciasis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: endogenous depression


subject: CHEBI:73604

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage III Ampulla of Vater Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Ampulla of Vater Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Ampulla of Vater Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Ampulla of Vater Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Gallbladder Cancer AJCC v6


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:90881

subject_name: Camptosar

object_name: digestive system cancer


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881

object_name: gastric adenocarcinoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863

object_name: Stage IIIB Gastric Carcinoma


subject: CHEBI:45863

object_name: Stage IIIA Gastric Carcinoma


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:45863

object_name: stage IIIA gallbladder cancer


subject: CHEBI:45863

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Adenocarcinoma of Unknown Primary


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: neoplasm


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: GTOPDB:4934

subject_name: G-CSF

object_name: retinoblastoma


subject: GTOPDB:4934

object_name: hepatoblastoma


subject: GTOPDB:4934

object_name: liver carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: GTOPDB:4942

subject_name: GM-CSF


subject: GTOPDB:4942


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: CHEBI:95021

subject_name: pemetrexed

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:95021

object_name: peritoneal carcinoma


subject: CHEBI:95021

object_name: malignant epithelial tumor of ovary


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C4745029

subject_name: HLX 10

object_name: Small cell lung cancer limited stage


subject: CHEBI:188074

object_name: diabetic neuropathy


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:44915

subject_name: Propofol

object_name: chronic rhinosinusitis


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEMBL.COMPOUND:CHEMBL2109032

subject_name: CALCIUM POLYCARBOPHIL

object_name: type 2 diabetes mellitus


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: cystic fibrosis-related diabetes


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: hematologic disorder


subject: CHEBI:44423

object_name: hemochromatosis


subject: CHEBI:44423

object_name: hemosiderosis


subject: CHEBI:44423

object_name: hemochromatosis type 1


subject: CHEBI:42944

subject_name: Galantamine

object_name: bipolar disorder


subject: CHEBI:42944

object_name: bipolar depression


subject: CHEBI:42944

object_name: major depressive disorder


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: polymyalgia rheumatica


subject: UMLS:C5761796

subject_name: GVAX

object_name: melanoma


subject: CHEBI:83766

subject_name: Olaparib

object_name: colorectal cancer


subject: CHEBI:83766

object_name: colorectal carcinoma


subject: CHEBI:83766

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB18587

subject_name: Zelpultide alfa

object_name: bronchopulmonary dysplasia


subject: DRUGBANK:DB18587

object_name: Bronchopulmonary Dysplasia, AE


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: osteonecrosis


subject: UNII:4988K7X26P

object_name: avascular necrosis


subject: UNII:4988K7X26P

object_name: Osteonecrosis, CTCAE


subject: UNII:4988K7X26P

object_name: sickle cell disease


subject: UNII:4988K7X26P

object_name: Ischemic Necrosis


subject: UNII:4988K7X26P

object_name: Avascular Necrosis, CTCAE


subject: CHEBI:2567

subject_name: Alendronic acid


subject: CHEBI:2567


subject: CHEBI:2567


subject: CHEBI:2567


subject: CHEBI:2567


subject: CHEBI:2567


subject: CHEBI:230508

subject_name: birabresib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:58008990

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:58008990

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:38940

subject_name: Sunitinib

object_name: von Hippel-Lindau disease


subject: CHEBI:8382

subject_name: Prednisone

object_name: Acute urticaria


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101


subject: UMLS:C2348637

object_name: non-Hodgkin lymphoma


subject: UMLS:C2348637

object_name: Hodgkin Disease


subject: UMLS:C1676059

subject_name: TMC 278

object_name: HIV-1 infection


subject: CHEBI:183415

object_name: cannabis abuse


subject: UNII:35A26E427H

subject_name: Reslizumab

object_name: asthma


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: Stage III Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage III Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44151801

object_name: Carcinoma of the prostate stage III


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage III Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage I Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:44151801

object_name: Prostate cancer stage I


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage I Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage I Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage IIA Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage IIA Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage IIB Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: UNII:08AN7WA2G0

subject_name: TRIPTORELIN PAMOATE


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0

object_name: prostate adenocarcinoma


subject: UMLS:C1145204

subject_name: INJECTION, TRIPTORELIN PAMOATE, 3.75 MG ADMINISTERED